- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00069654
Dietary Nitrate and Nitrite to Increase Nitric Oxide in Patients With Coronary Artery Disease
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease
This study will determine whether dietary nitrates and nitrites can produce nitric oxide in the body and dilate blood vessels in patients with coronary artery disease. Nitric oxide is normally made by endothelial cells that line blood vessels. It plays an important role in maintaining the normal function of arteries by keeping them open and preventing damage from substances such as cholesterol in the blood stream. Coronary artery disease is caused by atherosclerosis (hardening of the arteries or build-up of cholesterol and scar tissue within the walls of the arteries). Once arteries become clogged, the ability of the endothelium to produce nitric oxide diminishes considerably and may speed up the disease process, leading to shortness of breath, chest pain, and an increased risk of heart attack or stroke.
Patients 21 years of age and older with coronary artery disease may be eligible for this study. Participants will have a medical history and physical examination, electrocardiogram (recording of the electrical activity of the heart), echocardiogram (ultrasound test of the heart), treadmill exercise stress test (see below), and will meet with a dietitian. They will be hospitalized at the NIH Clinical Center on two occasions. For 1 week before each admission, they will follow a diet prescribed by an NIH nutritionist. The diet before one admission will be high in nitrates and nitrites, and the diet before the other admission will be low in nitrates and nitrites. Each admission will last 4 days, during which participants will undergo the following tests:
- Forearm blood flow study: Small tubes are placed in the artery and vein at the inside of the elbow of the dominant arm (right- or left-handed) and a small tube is placed in a vein of the other arm. The tubes are used for infusing saline (salt water) and for drawing blood samples. A pressure cuff is placed around the upper part of the dominant arm, and a rubber band device called a strain gauge is also placed around the arm to measure blood flow. When the cuff is inflated, blood flows into the arm, stretching the strain gauge at a rate proportional to the flow. Maximum grip-strength of the dominant arm is measured with a dynamometer. Forearm blood flow is measured and blood samples are drawn at the following times: 20 minutes after the tubes are placed; during a hand-grip exercise; and 4 minutes after the exercise is completed.
- Brachial artery reactivity study: This test measures h...
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Maryland
-
Bethesda, Maryland, United States, 20892
- National Institutes of Health Clinical Center, 9000 Rockville Pike
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
- INCLUSION CRITERIA:
Adults older than 21 years.
Coronary artery disease established by angiography.
No myocardial infarction within 1 month.
Left ventricular ejection fraction greater than 30%.
No congestive heart failure symptoms within 2 months.
Subject provides written, informed consent.
EXCLUSION CRITERIA:
Significant structural heart disease (e.g. hypertrophic or dilated cardiomyopathy, valvular heart disease) as determined by echocardiography.
Subject physically unable to perform treadmill exercise due to neurologic or orthopedic conditions.
Hypersensitivity to organ nitrates.
Insulin-dependant diabetes mellitus.
Coumadin therapy (because of vitamin K content of green leafy vegetables).
Women of childbearing age unless recent pregnancy test is negative.
Lactating women.
Unwillingness to adhere to dietary requirements or allergy to necessary components of diets, as determined during interview by the dietician.
Surgical or disease-related diminished acid secretion.
Significant non-cardiac disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Comparison of forearm blood flow during exercise after 3 days of the nitrate-nitrite-enriched diet to forearm blood flow during exercise after 3 days of the nitrate/nitrite-restricted diet.
Time Frame: Measured on day 4 of the nitrite/nitrate enriched and restricted diet
|
Measured on day 4 of the nitrite/nitrate enriched and restricted diet
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Comparison of effects of high versus low nitrate/nitrite diets on exercise forearm blood flow between the two cohorts of patients.
Time Frame: Measured on day 4 of the nitrite/nitrate enriched and restricted diet.
|
Measured on day 4 of the nitrite/nitrate enriched and restricted diet.
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373-6. doi: 10.1038/288373a0.
- Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664-6. doi: 10.1038/333664a0.
- Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11-17;327(6122):524-6. doi: 10.1038/327524a0.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 030312
- 03-H-0312
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Arteriosclerosis
-
Johns Hopkins UniversityNorthwestern UniversityCompletedCoronary Artery Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Atherosclerosis, Coronary | Arteriosclerosis, CoronaryUnited States
-
Region Örebro CountyTerminatedCoronary Stenosis | Calcific Coronary ArteriosclerosisSweden
-
Leiden University Medical CenterShockwave Medical, Inc.Enrolling by invitationCalcific Coronary ArteriosclerosisNetherlands, Greece, Belgium
-
Luzerner KantonsspitalHôpital Fribourgeois; Hamilton General HospitalRecruitingCoronary Artery Disease | Coronary Disease | Coronary Artery Calcification | Stent Restenosis | Calcific Coronary ArteriosclerosisSwitzerland
-
Cordis CorporationCompletedCoronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous Coronary | Peripheral ArteriosclerosisUnited States
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
MultiplAI Health LimitedFundación para la Lucha contra las Enfermedades Neurológicas de la InfanciaEnrolling by invitationCoronary Stenosis | Atherosclerotic Plaque | Aortic Calcification | Calcific Coronary Arteriosclerosis | Coronary PlaqueArgentina
-
Hemoteq AGCompletedCoronary Artery Disease | Coronary Arteriosclerosis | Coronary Atherosclerosis | Coronary RestenosisGermany, France
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, ZürichRecruitingCoronary Artery Disease | Coronary Arteriosclerosis | Coronary; IschemicSwitzerland
-
Meshalkin Research Institute of Pathology of CirculationCompletedCoronary Artery Disease | Coronary ArteriosclerosesRussian Federation
Clinical Trials on Forearm blood flow study
-
University of EdinburghUniversity of Aarhus; University of OxfordCompleted
-
University of EdinburghNHS LothianCompletedHeart Disease | Vascular DiseaseUnited Kingdom
-
Medical University of ViennaCompletedHypertension | Diabetes Mellitus, Type 1 | Hypercholesterolemia | Regional Blood FlowAustria
-
University of EdinburghUniversity of Aarhus; University of OxfordCompletedIschaemic Heart DiseasesUnited Kingdom
-
University of EdinburghUniversity of Aarhus; University of OxfordCompletedIschaemic Heart DiseasesUnited Kingdom
-
Northwestern UniversityRecruitingHypertension | Obesity | Hypertension in PregnancyUnited States
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedPostural Tachycardia Syndrome (POTS)United States
-
China Medical University HospitalCompletedBlood Flow Restriction | draw-in Maneuver | Transverse AbdominisTaiwan
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)RecruitingThrombocytopenia | Surgery | Acute Kidney Injury | HemolysisUnited States
-
George Fox UniversityUnknownMuscle Weakness | Can Blood Flow Restriction Therapy Augments Strength Gains in the Rotator CuffUnited States